Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2026-02-23 @ 12:19 PM
Study NCT ID:
NCT00655161
Status:
COMPLETED
Last Update Posted:
2014-01-29
First Post:
2008-04-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation
Sponsor:
GlobeImmune
Organization: